Sensei Biotherapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Cambrian BioPharma Inc | — | Purchase | 2,458 | $3.60 | $8,849 | 5,230,786 | Feb 28, 2022 |
| Peyer James | — | Purchase | 2,500 | $3.65 | $9,125 | 5,228,286 | Feb 25, 2022 |
| Cambrian BioPharma Inc | — | Purchase | 2,500 | $3.65 | $9,125 | 5,228,286 | Feb 25, 2022 |
| Cambrian BioPharma Inc | — | Purchase | 2,500 | $3.80 | $9,500 | 5,210,786 | Feb 24, 2022 |
| Peyer James | — | Purchase | 15,000 | $3.63 | $54,450 | 5,225,786 | Feb 23, 2022 |
| Peyer James | — | Purchase | 4,949 | $4.17 | $20,637 | 5,193,286 | Feb 18, 2022 |
| Cambrian BioPharma Inc | — | Purchase | 15,000 | $3.97 | $59,550 | 5,208,286 | Feb 17, 2022 |
| Cambrian BioPharma Inc | — | Purchase | 10,000 | $4.18 | $41,800 | 5,185,786 | Feb 16, 2022 |
| Peyer James | — | Purchase | 10,000 | $4.18 | $41,800 | 5,185,786 | Feb 16, 2022 |
| Pierce Robert Hamilton | Chief R&D Officer | Award / Grant | 21,000 | — | — | 21,000 | Feb 15, 2022 |
| Colgan Erin | Chief Financial Officer | Award / Grant | 21,000 | — | — | 21,686 | Feb 15, 2022 |
| Celebi John | President and CEO | Award / Grant | 53,900 | — | — | 54,114 | Feb 15, 2022 |
| Peyer James | — | Purchase | 5,000 | $4.58 | $22,900 | 5,163,286 | Feb 11, 2022 |
| Cambrian BioPharma Inc | — | Purchase | 5,000 | $4.58 | $22,900 | 5,163,286 | Feb 11, 2022 |
| Cambrian BioPharma Inc | — | Purchase | 10,000 | $4.33 | $43,300 | 5,158,286 | Feb 4, 2022 |
| Peyer James | — | Purchase | 2,500 | $4.45 | $11,125 | 5,148,286 | Feb 3, 2022 |
| Cambrian BioPharma Inc | — | Purchase | 8,900 | $4.22 | $37,558 | 5,128,286 | Jan 27, 2022 |
| Peyer James | — | Purchase | 8,900 | $4.22 | $37,558 | 5,128,286 | Jan 27, 2022 |
| Peyer James | — | Purchase | 20,100 | $4.86 | $97,686 | 5,083,386 | Jan 26, 2022 |
| Cambrian BioPharma Inc | — | Purchase | 29,900 | $4.62 | $138,138 | 5,113,286 | Jan 25, 2022 |
| Cambrian BioPharma Inc | — | Purchase | 24,703 | $4.94 | $122,033 | 5,040,579 | Jan 24, 2022 |
| Peyer James | — | Purchase | 22,707 | $4.69 | $106,496 | 5,063,286 | Jan 21, 2022 |
| Peyer James | — | Purchase | 20,000 | $5.17 | $103,400 | 5,015,876 | Jan 19, 2022 |
| Cambrian BioPharma Inc | — | Purchase | 20,000 | $5.17 | $103,400 | 5,015,876 | Jan 19, 2022 |
| Peyer James | — | Purchase | 10,000 | $5.08 | $50,800 | 4,985,632 | Jan 18, 2022 |
| Cambrian BioPharma Inc | — | Purchase | 10,000 | $5.08 | $50,800 | 4,985,632 | Jan 18, 2022 |
| Cambrian BioPharma Inc | — | Purchase | 19,953 | $5.13 | $102,359 | 4,969,413 | Jan 14, 2022 |
| Peyer James | — | Purchase | 6,219 | $4.99 | $31,033 | 4,975,632 | Jan 13, 2022 |
| Peyer James | — | Purchase | 10,845 | $5.18 | $56,177 | 4,940,258 | Jan 12, 2022 |
| Cambrian BioPharma Inc | — | Purchase | 9,202 | $5.22 | $48,034 | 4,949,460 | Jan 11, 2022 |
| Peyer James | — | Purchase | 10,000 | $5.28 | $52,800 | 4,929,413 | Jan 10, 2022 |
| Cambrian BioPharma Inc | — | Purchase | 10,000 | $5.28 | $52,800 | 4,929,413 | Jan 10, 2022 |
| Peyer James | — | Purchase | 1,127 | $4.85 | $5,466 | 4,919,413 | Dec 30, 2021 |
| Cambrian BioPharma Inc | — | Purchase | 69,000 | $4.98 | $343,620 | 4,918,286 | Dec 29, 2021 |
| Peyer James | — | Purchase | 69,000 | $4.98 | $343,620 | 4,918,286 | Dec 29, 2021 |
| Cambrian BioPharma Inc | — | Purchase | 11,288 | $5.28 | $59,601 | 4,849,286 | Dec 28, 2021 |
| Peyer James | — | Purchase | 11,288 | $5.28 | $59,601 | 4,849,286 | Dec 28, 2021 |
| Cambrian BioPharma Inc | — | Purchase | 3,712 | $5.30 | $19,674 | 4,837,998 | Dec 27, 2021 |
| Peyer James | — | Purchase | 3,712 | $5.30 | $19,674 | 4,837,998 | Dec 27, 2021 |
| Cambrian BioPharma Inc | — | Purchase | 11,000 | $5.27 | $57,970 | 4,834,286 | Dec 23, 2021 |
| Peyer James | — | Purchase | 11,000 | $5.27 | $57,970 | 4,834,286 | Dec 23, 2021 |
| Cambrian BioPharma Inc | — | Purchase | 117 | $5.29 | $619 | 4,823,286 | Dec 17, 2021 |
| Peyer James | — | Purchase | 117 | $5.29 | $619 | 4,823,286 | Dec 17, 2021 |
| Peyer James | — | Purchase | 10,925 | $5.25 | $57,356 | 4,823,169 | Dec 16, 2021 |
| Cambrian BioPharma Inc | — | Purchase | 10,925 | $5.25 | $57,356 | 4,823,169 | Dec 16, 2021 |
| RICKS THOMAS G | — | Purchase | 20,000 | $6.62 | $132,400 | 321,769 | Dec 10, 2021 |
| Pierce Robert Hamilton | Chief Scientific Officer | Sale | 16,030 | $7.34 | $117,660 | — | Aug 11, 2021 |
| Pierce Robert Hamilton | Chief Scientific Officer | Sale | 6,982 | $7.06 | $49,293 | 82,380 | Aug 6, 2021 |
| Peyer James | — | Purchase | 350 | $12.00 | $4,200 | 4,812,244 | May 5, 2021 |
| Cambrian BioPharma Inc | — | Purchase | 350 | $12.00 | $4,200 | 4,812,244 | May 5, 2021 |